Tamsulosin: Difference between revisions

Latest revision as of 13:23, 1 July 2024

Citable Version ^[?]

This editable Main Article is under development and subject to a disclaimer.

[edit intro]

In medicine, tamsulosin is a selective antagonist of alpha1-adrenergic receptors.

Flomax brand of tamsulosin was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 1997.^[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2007.^[2]

Some content on this page may previously have appeared on Wikipedia.

@@ Line 1: / Line 1: @@
 {{subpages}}
 In [[medicine]], '''tamsulosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
+{{TOC|right}}
+==History==
+Flomax brand of tamsulosin was approved by the [[Food and Drug Administration]] in the [[United States of America|United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1997.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=020579 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=077451 Drugs@FDA]. U S Food and Drug Administration</ref>
-==External links==
+==Pharmacology==
-{{CZMed}}
+===Administration===
+===Distribution===
+===Metabolism===
+===Excretion===
+===Toxicity===
+==Attribution==
+{{WPAttribution}}
+==References==
+<references/>